Patent ID: 7157478

Claim:
A compound of formula I: wherein the moiety X—R is attached at one of the positions indicated by an asterisk; X is a 5-(R-substituted)-1,2,4-oxadiazol-3-yl moiety; and R is selected from: (i) a non-aromatic hydrocarbon group of up to 10 carbon atoms, optionally substituted with halogen, CF 3 , CHF 2 , CN, OH, CO 2 H, C 2-6 acyl, C 1-4 alkoxy or C 1-4 alkoxycarbonyl; (ii) a non-aromatic heterocyclic group comprising up to 7 ring atoms of which up to 3 are chosen from N, O and S and the remainder are carbon, bearing 0–3 substituents independently selected from oxo, halogen, CN, C 1-6 alkyl, OH, CF 3 , CHF 2 , CH 2 F, C 2-6 acyl, CO 2 H, C 1-4 alkoxy and C 1-4 alkoxycarbonyl; and (iii) phenyl or 6-membered heteroaryl, either of which bears 0–3 substituents independently selected from halogen, CF 3 , CHF 2 , CH 2 F, NO 2 , CN, OCF 3 , C 1-6 alkyl and C 1-6 alkoxy; or a pharmaceutically acceptable salt thereof.